Pegalan, Fred Vincent F.

HRN: 01-55-50  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2023
CO-AMOXICLAV 625MG (TAB)
06/05/2023
06/12/2023
PO
625mg
Bid
S/P Exlap, Resection And Anastomosis, Lavage, Jp Drain Application
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: